CVS has said thatselling off some Medicare prescription-drug plans wouldn't have amaterial impact on the expected benefits of the Aetnadeal.
Aetna Inc. said it plans to sell its Medicare prescription-drugbusiness to WellCare Health Plans Inc., a key step towardcompleting its $67.5 billion merger with CVS Health Corp.
Financial terms of the deal weren't disclosed. In a securitiesfiling, Aetna said that the “purchase price is not material” to thecompany. The divestiture of the Medicare Part D plans to WellCare may helpresolve objections to the CVS-Aetna deal from U.S. antitrust regulators.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
